The former encodes the multidrug and toxin extrusion protein 1 (MATE1) and has been linked with cellular uptake and sensitivity to the anticancer drug imatinib [142], while mutations in the latter cause the neurodegenerative disease of ataxia-telangiectasia [143]. This evidence concerns the gene SLC47A1 and ataxia telangiectasia.